Marie Benaiteau

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Journal: Journal for immunotherapy of cancer

Published: May 28, 2026

Sensitivity of the UT-Hopkins Score in 350 patients with antibody-mediated autoimmune encephalitis.

Sensitivity of the UT-Hopkins Score in 350 patients with antibody-mediated autoimmune encephalitis.

Journal: Journal of neurology

Published: April 24, 2026

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 13, 2026

Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease.

Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 08, 2025

Paraneoplastic Brachial Amyotrophic Diplegia With Favorable Outcome and Anti-Ank3 Antibodies: A Case Report.

Paraneoplastic Brachial Amyotrophic Diplegia With Favorable Outcome and Anti-Ank3 Antibodies: A Case Report.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 06, 2025

Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.

Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 18, 2025

Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.

Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 18, 2025

Anti-AK5 limbic encephalitis in a patient with pleural mesothelioma.

Anti-AK5 limbic encephalitis in a patient with pleural mesothelioma.

Journal: Journal of neurology

Published: July 10, 2025

Managing paraneoplastic GABABR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case report.

Managing paraneoplastic GABABR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case report.

Journal: BMC neurology

Published: May 08, 2025

Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies.

Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies.

Journal: Therapeutic advances in neurological disorders

Published: May 05, 2025

Caregivers' perspectives on long-term cognitive, psychiatric, psychological, and social outcomes in NMDAR encephalitis: Initial findings from the multi-center prospective SAPIENCE study.

Caregivers' perspectives on long-term cognitive, psychiatric, psychological, and social outcomes in NMDAR encephalitis: Initial findings from the multi-center prospective SAPIENCE study.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: March 25, 2025

Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.

Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.

Journal: Journal of neurology

Published: March 18, 2025

Showing 1-12 of 47

Last Updated: 09/26/2026